SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing heightened market volatility and active investor debate following reports that Berkshire Hathaway has fully exited its stake in the company. While some traders view this as a potential risk-off signal that could trigger a near-term reprice, others are dismissing the move as noise, pointing to the company's resilient fundamentals, strong earnings outlook, and growing integration of AI into its operations as reasons to maintain a long-term bullish stance.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is facing intense scrutiny and volatility as investors grow frustrated with the stock's underperformance relative to Ethereum, fueled by debates over management's accumulation strategy and broader crypto market stagnation. While some community members view recent price dips as a long-term accumulation opportunity ahead of potential legislative clarity, others are actively calling out the CEO for failed price projections and aggressive dilution.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors prepare for an oral plenary presentation at the AUA Annual Meeting featuring highly anticipated extended follow-up data for its prostate cancer therapy, CAN-2409. Community discussion is intensely focused on the potential for this data to establish a new standard of care, with significant speculation surrounding the drug's long-term durability and its appeal as a premium buyout candidate for major pharmaceutical firms.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust (SLV) is witnessing heightened volatility and intense social media debate, driven by a combination of macroeconomic inflationary pressures, geopolitical concerns, and emerging industrial demand for silver in AI data center infrastructure. The community is sharply divided between "stackers" who view recent price dips as a strategic buying opportunity and skeptics who interpret the erratic price action as evidence of market manipulation and the conclusion of the recent bullish trend.

Trio-Tech International engages in the provision of third-party semiconductor testing and burn-in services. It operates through the following segments: Semiconductor Back-End Solutions (SBS) and Industrial Electronics. The SBS segment is focused on the sale of burn-in and reliability test equipment used in the back-end manufacturing processes of semiconductors. Its equipment includes burn-in systems, burn-in boards, and related equipment that is used in the testing of structural integrity of integrated circuits. The Industrial Electronics segment consists of designing, manufacturing, and distributing a range of tests, processes, and other equipment used in the manufacturing processes of customers in various industries in the consumer and industrial market. The company was founded in 1958 and is headquartered in Los Angeles, CA.

Trio-Tech International

Trio-Tech International is trending as investors draw comparisons to high-growth semiconductor testing peers, citing its exposure to AI and EV chip demand. The community is actively discussing the company's potential for a valuation re-rating, fueled by its recent revenue growth, expansion of testing capacity, and a relatively small market cap that amplifies volatility.

Macy's, Inc. engages in the retail of apparel, accessories, cosmetics, home furnishings, and other consumer goods. The firm's brands include Macy's, Bloomingdale's, and Bluemercury. It offers men's, women's, and children's apparel, women's accessories, intimate apparel, shoes, cosmetics, fragrances, as well as home and miscellaneous products. The company was founded by Rowland H. Macy in 1858 and is headquartered in New York, NY.

Macy`s Inc

Macy's Inc

Macy's is trending following a better-than-expected quarterly earnings report where the company beat estimates and raised its full-year guidance, signaling improved momentum from store revamps and strategic growth initiatives. The community is actively debating whether this performance marks a sustainable turnaround or a temporary relief bounce, while also closely watching broader retail sector trends and potential impacts from macroeconomic headwinds.

Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.

Generate Biomedicines Inc

Generate Biomedicines is generating significant market buzz amid conflicting community reports regarding a potential stake by Nvidia, while traders debate the impact of recent insider activity and the company's generative AI-driven drug discovery platform.

SolarEdge Technologies, Inc. engages in the development of energy technology, which provides inverter solutions. The firm operates through the following segments: Solar and All Other. The Solar segment includes the design, development, manufacturing, and sales of an inverter solution designed to maximize power generation. The All Other segment includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products, and automated machines. Its products and services include photovoltaic inverters, power optimizers, photovoltaic monitoring, software tools, and electric vehicle chargers. The company was founded by Guy Sella, Lior Handelsman, Yoav Galin, Meir Adest, and Amir Fishelov on August 7, 2006 and is headquartered in Herzliya, Israel.

Solaredge Technologies Inc

SolarEdge is seeing intense community debate as the stock experiences a sharp rebound driven by a strategic pivot toward AI data center infrastructure and high-voltage energy storage solutions. While momentum traders are actively targeting a short squeeze amid improved sentiment, skeptics remain focused on the company's underlying fundamentals and the potential for volatility following recent earnings performance.

DEGEN is a reward token for Farcaster users, born from meme culture. It features a unique tipping system that allows the community to reward high-quality content creators. DEGEN also powers the Degen Chain, one of the pioneering Layer 3s launched on Base. Known as the “Las Vegas of blockchains,” it provides a platform for building and using Degen apps, offering a space for fun, innovation, and community-driven experiences.

League of Degens 

The Degen community is actively discussing potential upcoming catalysts, including a beta app launch, strategic token buybacks, and ongoing brand building efforts. Despite price volatility, investors remain focused on long-term growth and the potential for increased visibility through future exchange listings and expanded marketing.

About Suku: At Suku, we develop user-friendly tools for everyday users and creators to fully take advantage of all opportunities that Web3 provides—without the complexities or the need for technical knowledge.  Our Mission: We stand for a world where everyone has access to the benefits of Web3 without the complexity that has traditionally been associated with it. We believe that Web3 has the power to improve the way we interact with each other and the world, and we want to make it accessible to everyone.  That is why our mission is to transform every internet user into a web3 user by making simple and intuitive tools that allow them to fully benefit from the utilities of Web3 in all areas of their lives.  The Suku Approach: While most web3 companies focus on creating new decentralized solutions for the crypto niche (around 350 million users), Suku's roadmap revolves around building decentralized solutions that are easy to use for internet users worldwide (approximately 5 billion users).  We firmly believe that the success of Web3 hinges on meeting users where they already are, switching the mindset from 'Let's bring people to Web3' to 'Let's bring the benefits of Web3 to the people'—emphasizing benefits, accessibility, and user-friendliness, particularly during the onboarding stages.  Discover Suku: https://suku.world

SUKU

SUKU is trending amid heavy community scrutiny regarding persistent token dilution, lack of transparency, and skepticism over the project's utility. While some traders attempt to speculate on potential volatility or price breakouts, many vocal participants are questioning its ongoing listing on major exchanges and expressing frustration over its sustained underperformance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

QXO, Inc. (QXO) Reports Q1 Loss, Beats Revenue Estimates

QXO INC (QXO) delivered earnings and revenue surprises of -29.73% and +0.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

QXO Reports First Quarter 2026 Results

QXO, Inc. (QXO or the Company) (NYSE: QXO) today issued its financial results for the first quarter 2026. The Company reported a basic and diluted loss per common share of $(0.35) and an Adjusted...

QXO Posts Investor Q&A to Website

QXO, Inc. (NYSE: QXO), today posted an investor Q&A document to its website. The document was also filed by QXO as an exhibit to a Form 8-K with the U.S. Securities and Exchange Commission. The Q&A...

Oppenheimer Raises PT on QXO (QXO) Stock

Oppenheimer Raises PT on QXO (QXO) Stock...

Analysts Estimate QXO, Inc. (QXO) to Report a Decline in Earnings: What to Look Out for

QXO INC (QXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BlackSky Technology Inc. (BKSY) Reports Q1 Loss, Lags Revenue Estimates

BlackSky Technology (BKSY) delivered earnings and revenue surprises of -120.13% and -26.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

UBS Group AG Acquires 640,168 Shares of QXO, Inc. $QXO

UBS Group AG boosted its holdings in shares of QXO, Inc. (NYSE:QXO - Free Report) by 14.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,978,172 shares of the company's stock after acquiring an additional 640,1...

Oppenheimer & Co. Inc. Has $6.75 Million Stock Holdings in QXO, Inc. $QXO

Oppenheimer & Co. Inc. increased its position in shares of QXO, Inc. (NYSE:QXO - Free Report) by 30.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 350,006 shares of the company's s...

QXO, Inc. $QXO Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. cut its position in shares of QXO, Inc. (NYSE:QXO - Free Report) by 1.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional...

Mitsubishi UFJ Trust & Banking Corp Makes New $17.69 Million Investment in QXO, Inc. $QXO

Mitsubishi UFJ Trust & Banking Corp purchased a new stake in shares of QXO, Inc. (NYSE:QXO - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange...

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

Investors are weighing the ambitious long-term target of achieving $50 billion in revenue through Brad Jacobs’ aggressive roll-up strategy and digital transformation.

Market sentiment remains pressured as the stock navigates a soft building products sector, in-line earnings reports, and ongoing integration of major acquisitions.

Frustrated shareholders are divided between extreme volatility and the potential for a short squeeze as high short interest clashes with conviction-based long-term buying.

A dedicated group of traders is aggressively dollar-cost averaging into the recent drawdown, betting on the historical success of the leadership team.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.10	--	--	N/A
Q1 '26	-$0.10	-$0.12	-24.79%	MISSED
Q4 '25	$0.02	$0.02	1.93%	BEAT
Q3 '25	$0.12	$0.14	12.16%	BEAT
Q2 '25	$0.04	$0.11	168.05%	BEAT

QXO
QXO Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest QXO News

QXOQXO Inc.